17 results on '"Antje Bürger"'
Search Results
2. Genome wide conditional mouse knockout resources
- Author
-
Nadia Rosenthal, Edward Ryder, Jens Hansen, Janet Rossant, Ralf Kühn, Lydia Teboul, Barry Rosen, Cornelia Kaloff, Steve D.M. Brown, Terry Meehan, Susan Marschall, Yann Herault, Haydn M. Prosser, Gautier Koscielny, P. J. de Jong, Paul N. Schofield, S. Martínez, Frank Schnütgen, R. G. Lopez, Vivek Iyer, Kevin C K Lloyd, Hilary Gates, A. F. Stewart, Richard Baldock, Colin McKerlie, Francesco Chiani, Andras Nagy, Wendy Bushell, Martin Ringwald, Geoff Hicks, H. von Melchner, Paul Flicek, J.T. Eppig, A. Pombero, Wolfgang Wurst, Elizabeth M. Simpson, William C. Skarnes, Martin Fray, M. Hrabé de Angelis, Mohammed Selloum, Ramiro Ramirez-Solis, Andreas Hörlein, Stephen A. Murray, Joel Schick, Anthony P. West, G. P. Tocchini Valentini, Richard H. Finnell, Damian Smedley, Guillaume Pavlovic, Lauryl M. J. Nutter, J. Beig, Brendan Doe, Konstantinos Anastassiadis, Marie-Christine Birling, Claudia Seisenberger, Alessia Gambadoro, Mark W. Moore, Allan Bradley, David M. Valenzuela, Colin Fletcher, Francis S. Collins, Antje Bürger, Roland H. Friedel, P. Liu, Abdel Ayadi, P. Ruiz Noppinger, European Commission, National Institutes of Health (US), and Agence Nationale de la Recherche (France)
- Subjects
0301 basic medicine ,Genetics ,Mutant ,Gene targeting ,Biology ,Genome ,Embryonic stem cell ,International Knockout Mouse Consortium ,03 medical and health sciences ,030104 developmental biology ,Gene trapping ,Research community ,Drug Discovery ,Molecular Medicine ,ddc:610 ,Gene - Abstract
Novel development in mouse phenotyping 2014: et al., The International Knockout Mouse Consortium (IKMC) developed high throughput gene trapping and gene targeting pipelines that produced mostly conditional mutations of more than 18,500 genes in C57BL/6N mouse embryonic stem (ES) cells which have been archived and are freely available to the research community as a frozen resource. From this unprecedented resource more than 6000 mutant mouse strains have been generated by the IKMC in collaboration with the International Mouse Phenotyping Consortium (IMPC). In addition, a cre-driver resource was established including 250 C57BL/6 cre-inducible mouse strains. Complementing the cre-driver resource, a collection comprising 27 rAAVs expressing cre in a tissue-specific manner has also been produced. All resources are easily accessible from the IKMC/IMPC web portal (www.mousephenotype.org). The IKMC/IMPC resource is a standardized reference library of mouse models with defined genetic backgrounds enabling the analysis of gene-disease associations in mice of different genetic makeup and should therefore have a major impact on biomedical research., The authors are supported by the EUCOMMTOOLS project which is funded by the European Commission [FP7-HEALTH-F4-2010-261492] and UM1-HG006370-06 (TFM, JW); the National Insitute of Health U54 HG006370 (TFM, DS and SDMB), U42 OD011185 (SAM), HG006364-03S1 (KCKL), and U42 OD011175 (CM and KCKL); NorCommTLS (MRI, Government of Ontario) and Genome Canada (OG-090) (LMJN, CM); the Manitoba Research Innovation Fund (GGH); Genome British Columbia AGCP-CanEuCre-01 award (EMS). National Centre for Scientific Research (CNRS), the French National Institute of Health and Medical Research (INSERM), the University of Strasbourg (UDS), the “Centre Européen de Recherche en Biologie et en Médecine” the French state funds through the “Agence Nationale de la Recherche”, Investissements d’Avenir labelled ANR-10-IDEX-0002-02, ANR-10-LABX-0030-INRT, ANR-10-INBS-07 PHENOMIN to YH.
- Published
- 2016
- Full Text
- View/download PDF
3. Stability of Cryopreserved Samples of Mutant Mice
- Author
-
Dagmar Kerkau, Andreas Hörlein, Vincent von Walcke-Wulffen, Johannes Schenkel, Michael Ramin, Werner Nicklas, Antje Bürger, and Publica
- Subjects
Male ,Quality Control ,Genotype ,medicine.medical_treatment ,Embryonic Development ,Medicine (miscellaneous) ,Mice, Transgenic ,Fertilization in Vitro ,Biology ,General Biochemistry, Genetics and Molecular Biology ,Cryopreservation ,Embryo Culture Techniques ,Mice ,Animal science ,Microbiological contamination ,medicine ,Animals ,In vitro fertilisation ,business.industry ,Cell Biology ,General Medicine ,Embryo Transfer ,Spermatozoa ,Embryo transfer ,Genetically modified organism ,Biotechnology ,Blastocyst ,Female ,business - Abstract
Genetically modified animals are unique models with enormous scientific potential. Cryopreservation of pre-implantation embryos or of spermatozoa is a common approach to save those lines. The breeding of a line can be discontinued if a sufficient number of samples have been cryopreserved. To maintain the opportunity to recover a line, it is mandatory to assess the quality of the cryopreserved samples and to assure safe long-term storage conditions. Here, we investigated the revitalization rate of cryopreserved pre-implantation embryos stored in-house up to 158 months, of imported (and shipped) embryos, and of embryos received after in vitro fertilization. The storage period did not affect the revitalization rate, whereas the recovery of imported embryos was significantly reduced, possibly due to shipment conditions. The genotypes of genetically modified pups received following embryo-transfer were slightly smaller than expected by Mendelian laws. Intensive investigations of the hygienic state of the cryopreserved samples and the equipment used never showed microbiological contamination of a sample within a cryo-tube. However, environmental organisms were found frequently in the permanent freezers and dry shippers used. Since such contamination cannot be completely excluded and an embryo-transfer might not lead in all cases to a secure rederivation, foster mothers and revitalized pups should be housed in an intermediate facility and their health assessed before introducing them into the target facility.
- Published
- 2014
- Full Text
- View/download PDF
4. Early myeloid lineage choice is not initiated by random PU.1 to GATA1 protein ratios
- Author
-
Nadine Moritz, Dirk Loeffler, Nouraiz Ahmed, Heiko Lickert, Adriana Gambardella, Martin Etzrodt, Daniel L. Coutu, Konstantinos D. Kokkaliaris, Claus Nerlov, Michael Schwarzfischer, Bernhard Schauberger, Adam Filipczyk, Michael A. Rieger, Fabian J. Theis, Olga Ermakova, Philipp S. Hoppe, Timm Schroeder, Antje Bürger, Michael Strasser, Max Endele, Ingo Burtscher, Oliver Hilsenbeck, and Carsten Marr
- Subjects
Male ,0301 basic medicine ,Erythrocytes ,Lineage (genetic) ,Cellular differentiation ,Biology ,Models, Biological ,Monocytes ,Mice ,03 medical and health sciences ,Genes, Reporter ,Proto-Oncogene Proteins ,Animals ,Cell Lineage ,GATA1 Transcription Factor ,Myeloid Cells ,Transcription factor ,Gene ,Feedback, Physiological ,Genetics ,Stochastic Processes ,Multidisciplinary ,SPI1 ,Reproducibility of Results ,Cell Differentiation ,GATA1 ,Hematopoietic Stem Cells ,Hematopoiesis ,Haematopoiesis ,030104 developmental biology ,Trans-Activators ,Female ,Single-Cell Analysis ,Megakaryocytes ,Reprogramming ,Granulocytes - Abstract
The mechanisms underlying haematopoietic lineage decisions remain disputed. Lineage-affiliated transcription factors with the capacity for lineage reprogramming, positive auto-regulation and mutual inhibition have been described as being expressed in uncommitted cell populations. This led to the assumption that lineage choice is cell-intrinsically initiated and determined by stochastic switches of randomly fluctuating cross-antagonistic transcription factors. However, this hypothesis was developed on the basis of RNA expression data from snapshot and/or population-averaged analyses. Alternative models of lineage choice therefore cannot be excluded. Here we use novel reporter mouse lines and live imaging for continuous single-cell long-term quantification of the transcription factors GATA1 and PU.1 (also known as SPI1). We analyse individual haematopoietic stem cells throughout differentiation into megakaryocytic-erythroid and granulocytic-monocytic lineages. The observed expression dynamics are incompatible with the assumption that stochastic switching between PU.1 and GATA1 precedes and initiates megakaryocytic-erythroid versus granulocytic-monocytic lineage decision-making. Rather, our findings suggest that these transcription factors are only executing and reinforcing lineage choice once made. These results challenge the current prevailing model of early myeloid lineage choice.
- Published
- 2016
- Full Text
- View/download PDF
5. CRISPR-Cas9 enables conditional mutagenesis of challenging loci
- Author
-
Antje Bürger, Claudia Seisenberger, Sajith Perera, Wolfgang Wurst, Barry Rosen, Viola Maier, Joachim Beig, Vivek Iyer, William C. Skarnes, and Joel A. Schick
- Subjects
0301 basic medicine ,Mutant ,Biology ,Article ,International Knockout Mouse Consortium ,03 medical and health sciences ,Genome editing ,CRISPR ,Animals ,Vector (molecular biology) ,Gene ,genetics [CRISPR-Cas Systems] ,Genetics ,Mice, Knockout ,Multidisciplinary ,Gene targeting ,Embryonic stem cell ,ddc ,Mice, Inbred C57BL ,030104 developmental biology ,Mutagenesis ,Genetic Loci ,Gene Targeting ,genetics [Mutagenesis] ,CRISPR-Cas Systems ,ddc:600 - Abstract
The International Knockout Mouse Consortium (IKMC) has produced a genome-wide collection of 15,000 isogenic targeting vectors for conditional mutagenesis in C57BL/6N mice. Although most of the vectors have been used successfully in murine embryonic stem (ES) cells, there remain a set of nearly two thousand genes that have failed to target even after several attempts. Recent attention has turned to the use of new genome editing technology for the generation of mutant alleles in mice. Here, we demonstrate how Cas9-assisted targeting can be combined with the IKMC targeting vector resource to generate conditional alleles in genes that have previously eluded targeting using conventional methods.
- Published
- 2016
- Full Text
- View/download PDF
6. Brd2/RING3 Interacts with a Chromatin-Binding Domain in the Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen 1 (LANA-1) That Is Required for Multiple Functions of LANA-1
- Author
-
Thomas F. Schulz, Matthias Ottinger, Julie Sheldon, Regina König, Eva Brüning, Abel Viejo-Borbolla, Antje Bürger, and Emrah Kati
- Subjects
Transcription, Genetic ,viruses ,Immunology ,Protein Serine-Threonine Kinases ,Virus Replication ,medicine.disease_cause ,Microbiology ,Cell Line ,Virology ,medicine ,Transcriptional regulation ,Humans ,Gammaherpesvirinae ,Nuclear protein ,Kaposi's sarcoma-associated herpesvirus ,Antigens, Viral ,Sarcoma, Kaposi ,Genetics ,biology ,Chromatin binding ,Nuclear Proteins ,virus diseases ,Herpesviridae Infections ,biochemical phenomena, metabolism, and nutrition ,biology.organism_classification ,Nuclear matrix ,Chromatin ,Protein Structure, Tertiary ,Virus-Cell Interactions ,Viral replication ,Insect Science ,Herpesvirus 8, Human ,Plasmids ,Protein Binding ,Transcription Factors - Abstract
Latency-associated nuclear antigen 1 (LANA-1) of Kaposi's sarcoma-associated herpesvirus (KSHV) mediates the episomal replication of the KSHV genome, as well as transcriptional regulation, in latently infected cells. Interaction of LANA-1 with cellular chromatin is required for both these functions. An N-terminal heterochromatin-binding site in LANA-1 is essential for the replication and maintenance of latent episomes, as well as transcriptional regulation. We have recently described a C-terminal domain in LANA-1 that modulates the interaction with cellular interphase chromatin or elements of the nuclear matrix. Here, we used a series of LANA-1 deletion mutants to investigate the relationship between the different functions of LANA-1 and its interaction with the host chromatin-binding protein Brd2/RING3. Our findings suggest that the C-terminal chromatin-binding domain in LANA-1 is required for multiple LANA-1 functions, including the ability to bind to and replicate viral episomal DNA, to modulate transcription, and to interact with Brd2/RING3. Similar to the recently described tethering of bovine papillomavirus E2 protein to host chromatin via Brd4/MCAP, Brd2/RING3, another member of the Brd family of chromatin-binding proteins, therefore interacts with a chromatin-binding region of another viral latent nuclear protein and could play a role in its multiple functions.
- Published
- 2005
- Full Text
- View/download PDF
7. Tbx20 is essential for cardiac chamber differentiation and repression of Tbx2
- Author
-
Karin Schuster-Gossler, Marianne Petry, Andreas Kispert, Manvendra K. Singh, Antje Bürger, José M. Dias, Mark-Oliver Trowe, Vincent M. Christoffels, Johan Ericson, ACS - Amsterdam Cardiovascular Sciences, ARD - Amsterdam Reproduction and Development, and Medical Biology
- Subjects
TBX20 ,Mesenchyme ,Morphogenesis ,Apoptosis ,Biology ,Mice ,medicine ,Animals ,Molecular Biology ,Endocardium ,Body Patterning ,Cell Proliferation ,Mice, Knockout ,Myocardium ,Gene Expression Regulation, Developmental ,Cell Differentiation ,Heart ,Anatomy ,Embryonic stem cell ,Cell biology ,Repressor Proteins ,T-box ,medicine.anatomical_structure ,Cardiac chamber ,Mutation ,Atrioventricular canal ,T-Box Domain Proteins ,Developmental Biology - Abstract
Tbx20 , a member of the T-box family of transcriptional regulators, shows evolutionary conserved expression in the developing heart. In the mouse, Tbx20 is expressed in the cardiac crescent, then in the endocardium and myocardium of the linear and looped heart tube before it is restricted to the atrioventricular canal and outflow tract in the multi-chambered heart. Here, we show that Tbx20 is required for progression from the linear heart tube to a multi-chambered heart. Mice carrying a targeted mutation of Tbx20 show early embryonic lethality due to hemodynamic failure. A linear heart tube with normal anteroposterior patterning is established in the mutant. The tube does not elongate, indicating a defect in recruitment of mesenchyme from the secondary heart field, even though markers of the secondary heart field are not affected. Furthermore, dorsoventral patterning of the tube, formation of working myocardium, looping, and further differentiation and morphogenesis fail. Instead, Tbx2 , Bmp2 and vinexin α ( Sh3d4 ), genes normally restricted to regions of primary myocardium and lining endocardium, are ectopically expressed in the linear heart tube of Tbx20 mutant embryos. Because Tbx2 is both necessary and sufficient to repress chamber differentiation ([Christoffels et al., 2004a][1]; [Harrelson et al., 2004][2]), Tbx20 may ensure progression to a multi-chambered heart by repressing Tbx2 in the myocardial precursor cells of the linear heart tube destined to form the chambers. [1]: #ref-16 [2]: #ref-29
- Published
- 2005
- Full Text
- View/download PDF
8. Catecholamines stimulate interleukin-6 synthesis in rat cardiac fibroblasts
- Author
-
Antje Bürger, Markus Benicke, Alexander Deten, and Heinz-Gerd Zimmer
- Subjects
Agonist ,medicine.medical_specialty ,Adrenergic receptor ,Physiology ,medicine.drug_class ,Gene Expression ,Stimulation ,Biology ,Muscle hypertrophy ,Proinflammatory cytokine ,Rats, Sprague-Dawley ,Norepinephrine ,Physiology (medical) ,Internal medicine ,Receptors, Adrenergic, beta ,medicine ,Animals ,RNA, Messenger ,Autocrine signalling ,Phenylephrine ,Cells, Cultured ,Interleukin-6 ,Myocardium ,Fibroblasts ,Receptors, Adrenergic, alpha ,Receptor antagonist ,Rats ,Endocrinology ,Cytokines ,Female ,Cardiology and Cardiovascular Medicine ,medicine.drug - Abstract
Proinflammatory cytokines have been implicated in the pathophysiology of different heart diseases. Recent evidence suggests that interleukin-6 (IL--6) may play a role in mechanisms leading to cardiac hypertrophy. In addition, catecholamines are known to induce cardiac hypertrophy. In the present study, we examined whether cardiac fibroblasts may be a potential source of IL--6 production in the rat heart and whether catecholamines can modulate the IL--6 synthesis. Only a small amount of IL--6 mRNA was detected in unstimulated rat cardiac fibroblasts. However, a 50-fold increase of IL--6 mRNA was found after stimulation with norepinephrine (NE). Addition of carvedilol, a alpha- and beta-adrenergic receptor antagonist, prevented almost completely the NE-induced synthesis of IL--6 mRNA. Phenylephrine, an alpha-adrenergic agonist, and isoproterenol, a beta-adrenergic agonist, also induced an increase in IL--6. However, the stimulation via beta-receptors led to a more pronounced elevation. These data show that NE increases IL--6 expression in rat cardiac fibroblasts and that IL--6 may play an important autocrine/paracrine role in cardiac disease states associated with hypertrophy.
- Published
- 2001
- Full Text
- View/download PDF
9. Fibronectin synthesis by activated T lymphocytes: up-regulation of asurface-associated isoform with signalling function
- Author
-
Antje Bürger, François Hug, Gertrud Maria Hänsch, Markus Radsak, Stefan Blum, and Christof Wagner
- Subjects
Gene isoform ,Fibronectin ,Extracellular matrix ,Oligonucleotide ,Immunology ,biology.protein ,Immunology and Allergy ,IL-2 receptor ,Biology ,Receptor ,Ligand (biochemistry) ,Molecular biology ,Binding domain - Abstract
Fibronectin (FN) is a major constituent of the extracellular matrix. We now provide evidence for a surface-associated isoform of FN that is synthesized by T cells upon activation. The T-cell-derived FN has an unusual splice pattern: an additional domain, EDB, is produced whereas sequences within another domain, IIICS, are spliced out. CS1, the binding domain for very late antigen-4 (VLA-4), however, is still generated. To study the potential function of surface-associated FN its synthesis was down-regulated by an antisense oligonucleotide, then proliferation of T cells was induced by cross-linked anti-CD3. Proliferation was reduced as was expression of CD25. Moreover, when T cells were cultured in high density, the synthetic peptide QILDVPST, corresponding to CS1, inhibited proliferation, as did antibodies to VLA-4. We propose that surface-associated FN is a ligand for VLA-4, which by binding to VLA-4 on an adjacent cell, provides a costimulatory signal, thus sustaining T-cell proliferation.
- Published
- 2000
- Full Text
- View/download PDF
10. Fibronectin synthesis by human tubular epithelial cells in culture: Effects of PDGF and TGF-β on synthesis and splicing
- Author
-
Antje Bürger, Christof Wagner, Christiane Viedt, Bettina Reis, Friederike Hug, and Gertrud Maria Hänsch
- Subjects
Platelet-derived growth factor ,extracellular matrix ,RNA Splicing ,medicine.medical_treatment ,chemistry.chemical_compound ,sclerosis ,Transforming Growth Factor beta ,medicine ,Humans ,RNA, Messenger ,Cells, Cultured ,Platelet-Derived Growth Factor ,biology ,Growth factor ,Alternative splicing ,Epithelial Cells ,Fibronectins ,Cell biology ,Fibronectin ,Kidney Tubules ,chemistry ,Biochemistry ,Nephrology ,Cell culture ,RNA splicing ,biology.protein ,interstitial nephritis ,glomerulonephritis ,Platelet-derived growth factor receptor ,Transforming growth factor - Abstract
Fibronectin synthesis by human tubular epithelial cells in culture: Effects of PDGF and TGF-β on synthesis and splicing. Background Enhanced synthesis of extracellular matrix proteins including fibronectin (FN) is associated with the development of sclerosis. In this context we studied FN synthesis by tubular epithelial cells in response to transforming growth factor-β (TGF-β) and platelet-derived growth factor (PDGF). Methods FN protein synthesis by human tubular epithelial cells in culture (TEC) was measured by biosynthetic labeling and ELISA. Splicing of FN was assessed by RT-PCR and by Northern blotting. Results Cultivated TEC synthesized and released FN, the majority of which was deposited as an unsoluble protein and a minor portion (10 to 15%) was released into the supernatant. TGF-β and, to a lesser degree, PDGF, up-regulated FN synthesis. All three FN splice variants (EDA, EDB, and IIICS) were produced. PDGF did not influence the splicing. TGF-β preferentially up-regulated the EDA splice variant, but had no effect on the splicing of the other domains. Conclusions PDGF and TGF-β both up-regulate FN synthesis of TEC. TGF-β, but not PDGF, also changed the quality of the de novo synthesized FN, and thus has a different role in the development of sclerosis.
- Published
- 1998
- Full Text
- View/download PDF
11. Interaction of transforming growth factor β1 with human glomerular epithelial cells in culture: opposite effects on synthesis of matrix proteins and on urokinase plasminogen activator
- Author
-
Gertrud Maria Hänsch, S. Filsinger, M. Kramer, Christof Wagner, Antje Bürger, and Christiane Viedt
- Subjects
Renal glomerulus ,medicine.medical_treatment ,Matrix (biology) ,Extracellular matrix ,Transforming Growth Factor beta ,Drug Discovery ,medicine ,Humans ,Cells, Cultured ,Genetics (clinical) ,Extracellular Matrix Proteins ,biology ,Growth factor ,Epithelial Cells ,Urokinase-Type Plasminogen Activator ,Fibronectins ,Glomerular Mesangium ,Cell biology ,Fibronectin ,Cytokine ,Biochemistry ,biology.protein ,Molecular Medicine ,Collagen ,Plasminogen activator ,Transforming growth factor - Abstract
The effect of transforming growth factor-beta (TGF-beta) was analyzed on the synthesis of fibronectin, collagen type IV, and urokinase plasminogen activator in human glomerular epithelial cells in culture. An increase in the abundance of specific mRNA was found for collagen type IV and fibronectin. Fibronectin protein synthesis was also increased in TGF-beta treated cells; most of the de novo synthesized fibronectin was found as an unsoluble protein associated with extracellular matrix. In the same cells the amount of plasminogen activator mRNA was found leading also to a decreased surface expression of urokinase plasminogen activator. The data support the concept that by upregulating matrix protein synthesis and downregulating the plasminogen activator system, TGF-beta favors the development of sclerosis.
- Published
- 1996
- Full Text
- View/download PDF
12. Matrix protein synthesis by glomerular mesangial cells in culture: Effects of transforming growth factor β (TGFβ) and platelet-derived growth factor (PDGF) on fibronectin and collagen type IV mRNA
- Author
-
Christof Wagner, Antje Bürger, Wenjie Dong, G. Staehler, Michael Stoeck, and Gertrud Maria Hänsch
- Subjects
Platelet-derived growth factor ,biology ,Physiology ,Glomerular Mesangial Cell ,Clinical Biochemistry ,Cell Biology ,Transforming growth factor beta ,Molecular biology ,Fibronectin ,chemistry.chemical_compound ,chemistry ,TGF beta signaling pathway ,biology.protein ,Platelet-derived growth factor receptor ,TGF beta 1 ,Transforming growth factor - Abstract
The pathogenesis of glomerular scarring is multifactional; recent evidence suggests that transforming growth factor beta (TGF beta), a pleiotropic cicatricial mediator, may promote mesangial sclerosis by enhancing the production of extracellular matrix proteins. We studied the effect of TGF beta 1 and TFG beta 2 on collagen type IV and fibronectin (FN) synthesis in human glomerular mesangial cells in culture (GMC). Two hours after addition of TGF beta, an up to twofold increase in abundance of collagen type IV mRNA was found, which further increased up to fivefold within 24 h. Addition of cycloheximide did not inhibit the TGF beta effect, but caused by itself an up to twofold increase in the abundance of collagen type IV mRNA after 2 h. Together with collagen mRNA, the mRNA for FN and for platelet-derived growth factor (PDGF) was also enhanced. PDGF was found to enhance abundance of the collagen type IV and fibronectin mRNA in GMC. A neutralizing antibody to PDGF or a PDGF-antisense oligonucleotide partly inhibited the TGF beta-induced increase of collagen type IV mRNA, suggesting that TGF beta can affect the collagen type IV synthesis not only directly but also indirectly via the synthesis of PDGF.
- Published
- 1995
- Full Text
- View/download PDF
13. Up-regulation of intracellular calcium, cyclic adenosine monophosphate and fibronectin synthesis in tubuar epithelial cells by complement
- Author
-
Friederike Hug, Antje Bürger, Christof Wagner, and Gertrud Maria Hänsch
- Subjects
Immunology ,chemistry.chemical_element ,chemical and pharmacologic phenomena ,Context (language use) ,Complement Membrane Attack Complex ,Biology ,Calcium ,Calcium in biology ,chemistry.chemical_compound ,Downregulation and upregulation ,parasitic diseases ,Cyclic AMP ,Immunology and Allergy ,Humans ,Cyclic adenosine monophosphate ,Calcimycin ,Cells, Cultured ,Forskolin ,Epithelial Cells ,Complement System Proteins ,female genital diseases and pregnancy complications ,Transmembrane protein ,Cell biology ,Fibronectins ,Up-Regulation ,Fibronectin ,Kidney Tubules ,chemistry ,Biochemistry ,Bucladesine ,biology.protein - Abstract
The terminal complement complex C5b-9 is known to participate in inflammatory processes including glomerular or tubulointerstitial injury. Injury appears to be a direct consequence of C5b-9-mediated cell stimulation. In that context we studied activation of tubular epithelial cells by C5b-9 particularly with regard to fibronectin synthesis and the transmembrane signals involved. C5b-9 in sublytic concentrations caused a rise of intracellular calcium and of cAMP, followed by an increase in abundance of fibronectin-specific mRNA and accumulation of protein. Stabilized cAMP or increasing the cAMP level by forskolin enhanced fibronectin synthesis with similar kinetics. The effect of cAMP could be enhanced by adding a calcium ionophore. Since the fibronectin gene is known to have a cAMP-responsive element, the data suggest that C5b-9 increases fibronectin synthesis via generation of cAMP.
- Published
- 1999
14. Fibronectin synthesis in tubular epithelial cells: Up-regulation of the EDA splice variant by transforming growth factor β
- Author
-
Christiane Viedt, G. Maria Hänsch, and Antje Bürger
- Subjects
medicine.medical_treatment ,Molecular Sequence Data ,Cell ,Dexamethasone ,Extracellular matrix ,Downregulation and upregulation ,Transforming Growth Factor beta ,medicine ,Protein biosynthesis ,Humans ,RNA, Messenger ,Glucocorticoids ,Cells, Cultured ,Base Sequence ,biology ,Growth factor ,Epithelial Cells ,Molecular biology ,Fibronectins ,Up-Regulation ,Fibronectin ,Alternative Splicing ,Kidney Tubules ,medicine.anatomical_structure ,Cytokine ,Biochemistry ,Nephrology ,biology.protein ,Transforming growth factor - Abstract
Fibronectin synthesis in tubular epithelial cells: Up-regulation of the EDA splice variant by transforming growth factor β. The influence of transforming growth factor β1 (TGF-β1) and of dexamethasone on fibronectin (FN) synthesis of human renal tubular epithelial cells in culture (TEC) was studied. Cocultivation with TGF-β1 increased the steady state level of FN RNA within 24 to 48 hours. By PCR and Northern blotting it was found that the EDA splice variant of FN was preferentially up-regulated. To quantitate FN protein synthesis, cells were cultivated in the presence of [ 35 S]-methionine and FN was isolated from the cell supernatants, and the cell lysates by adsorption to gelatin-sepharose. In TGF-β1 treated cells, a small increase of FN in the cell supernatants was seen (1.7-fold), and a more prominent increase in the cell lysates (4.5-fold). The FN content of the extracellular matrix was also increased in TGF-β1 treated cells. Most of the de novo synthesized FN was identified as the EDA-variant of FN. As a further stimulus, dexamethasone was used. Again, an increase of FN-specific mRNA was seen as well as an increased FN protein synthesis. The ratio between FN and EDA-FN, however, was not altered when compared to untreated cells. Thus, an increase in EDA-FN synthesis is obviously stimulus dependent.
- Full Text
- View/download PDF
15. Expression of the 14kDa galactose-binding protein, galectin-1, on human tubular epithelial cells
- Author
-
Gertrud Maria Hänsch, Sabine Filsinger, Douglas N.W. Cooper, and Antje Bürger
- Subjects
Galectin 1 ,Blotting, Western ,Gene Expression ,HL-60 Cells ,Polymerase Chain Reaction ,Epithelium ,Laminin ,Gene expression ,Protein biosynthesis ,Cell Adhesion ,otorhinolaryngologic diseases ,Humans ,RNA, Messenger ,Messenger RNA ,biology ,Binding protein ,Lectin ,Galactose ,Epithelial Cells ,Blotting, Northern ,Flow Cytometry ,Molecular biology ,Immunohistochemistry ,Blot ,stomatognathic diseases ,Hemagglutinins ,Kidney Tubules ,Nephrology ,Polyclonal antibodies ,Antigens, Surface ,biology.protein ,Calcium ,Protein Binding - Abstract
Expression of the 14kDa galactose-binding protein, galectin-1, on human tubular epithelial cells. By reverse phase PCR and Northern blotting, RNA of the 14kDa galactose-binding protein (galectin-1) could be identified in primary cultures of human tubular epithelial cells. To assess protein synthesis and the possible function of galectin-1 on TEC, the cellular proteins were biosyntheticically labeled with [35S]-methionine and adsorbed to immobilized laminin. Multiple radiolabeled proteins were eluted, a strong band in the area of 14kDa was seen, coinciding with the galectin-1 band as identified by Western blotting. Surface expression of galectin-1 was seen by cytofluorometry with two different polyclonal antibodies to galectin-1. These data are in line with the finding that tubular epithelial cells adhere to laminin, partly in a Ca2+-independent manner.
- Full Text
- View/download PDF
16. Human and mouse essentiality screens as a resource for disease gene discovery
- Author
-
Cacheiro, Pilar, Muñoz-Fuentes, Violeta, Westerberg, Henrik, Scott, R. H., Siddiq, A., Sieghart, A., Smith, K. R., Sosinsky, A., Spooner, W., Stevens, H. E., Stuckey, A., Sultana, R., Thomas, E. R. A., Konopka, Tomasz, Thompson, S. R., Tregidgo, C., Tucci, A., Walsh, E., Watters, S. A., Welland, M. J., Williams, E., Witkowska, K., Wood, S. M., Zarowiecki, M., Hsu, Chih-Wei, Marschall, Susan, Lengger, Christoph, Maier, Holger, Seisenberger, Claudia, Bürger, Antje, Kühn, Ralf, Schick, Joel, Hörlein, Andreas, Oritz, Oskar, Giesert, Florian, Christiansen, Audrey, Beig, Joachim, Kenyon, Janet, Codner, Gemma, Fray, Martin, Johnson, Sara J, Cleak, James, Szoke-Kovacs, Zsombor, Lafont, David, Vancollie, Valerie E, McLaren, Robbie S B, Lanza, Denise G, Hughes-Hallett, Lena, Rowley, Christine, Sanderson, Emma, Galli, Antonella, Tuck, Elizabeth, Green, Angela, Tudor, Catherine, Siragher, Emma, Dabrowska, Monika, Mazzeo, Cecilia Icoresi, Beaudet, Arthur L, Griffiths, Mark, Gannon, David, Doe, Brendan, Cockle, Nicola, Kirton, Andrea, Bottomley, Joanna, Ingle, Catherine, Ryder, Edward, Gleeson, Diane, Ramirez-Solis, Ramiro, Heaney, Jason D, Birling, Marie-Christine, Pavlovic, Guillaume, Ayadi, Abdel, Hamid, Meziane, About, Ghina Bou, Champy, Marie-France, Jacobs, Hugues, Wendling, Olivia, Leblanc, Sophie, Vasseur, Laurent, Fuchs, Helmut, Chesler, Elissa J, Kumar, Vivek, White, Jacqueline K, Svenson, Karen L, Wiegand, Jean-Paul, Anderson, Laura L, Wilcox, Troy, Clark, James, Ryan, Jennifer, Denegre, James, Gailus-Durner, Valerie, Stearns, Tim, Philip, Vivek, Witmeyer, Catherine, Bates, Lindsay, Seavey, Zachary, Stanley, Pamela, Willet, Amelia, Roper, Willson, Creed, Julie, Moore, Michayla, Sorg, Tania, Dorr, Alex, Fraungruber, Pamelia, Presby, Rose, Mckay, Matthew, Nguyen-Bresinsky, Dong, Goodwin, Leslie, Urban, Rachel, Kane, Coleen, Murray, Stephen A, Prochazka, Jan, Novosadova, Vendula, Lelliott, Christopher J, Wardle-Jones, Hannah, Wells, Sara, Teboul, Lydia, Cater, Heather, Stewart, Michelle, Hough, Tertius, Wurst, Wolfgang, Dickinson, Mary E, Sedlacek, Radislav, Adams, David J, Seavitt, John R, Tocchini-Valentini, Glauco, Mammano, Fabio, Braun, Robert E, McKerlie, Colin, Herault, Yann, de Angelis, Martin Hrabě, Mallon, Ann-Marie, Bucan, Maja, Lloyd, K C Kent, Brown, Steve D M, Parkinson, Helen, Meehan, Terrence F, Smedley, Damian, Consortium, Genomics England Research, Consortium, International Mouse Phenotyping, Ambrose, J. C., Arumugam, P., Baple, E. L., Nutter, Lauryl M J, Bleda, M., Boardman-Pretty, F., Boissiere, J. M., Boustred, C. R., Brittain, H., Caulfield, M. J., Chan, G. C., Craig, C. E. H., Daugherty, L. C., de Burca, A., Peterson, Kevin A, Devereau, A., Elgar, G., Foulger, R. E., Fowler, T., Furió-Tarí, P., Hackett, J. M., Halai, D., Hamblin, A., Henderson, S., Holman, J. E., Haselimashhadi, Hamed, Hubbard, T. J. P., Ibáñez, K., Jackson, R., Jones, L. J., Kasperaviciute, D., Kayikci, M., Lahnstein, L., Lawson, K., Leigh, S. E. A., Leong, I. U. S., Flenniken, Ann M, Lopez, F. J., Maleady-Crowe, F., Mason, J., McDonagh, E. M., Moutsianas, L., Mueller, M., Murugaesu, N., Need, A. C., Odhams, C. A., Patch, C., Morgan, Hugh, Perez-Gil, D., Polychronopoulos, D., Pullinger, J., Rahim, T., Rendon, A., Riesgo-Ferreiro, P., Rogers, T., Ryten, M., Savage, K., Sawant, K., Cacheiro, Pilar [0000-0002-6335-8208], Muñoz-Fuentes, Violeta [0000-0003-3574-546X], Nutter, Lauryl MJ [0000-0001-9619-146X], Peterson, Kevin A [0000-0001-8353-3694], Haselimashhadi, Hamed [0000-0001-7334-2421], Konopka, Tomasz [0000-0003-3042-4712], Hsu, Chih-Wei [0000-0002-9591-9567], Lanza, Denise G [0000-0001-8750-6933], Heaney, Jason D [0000-0001-8475-8828], Fuchs, Helmut [0000-0002-5143-2677], Gailus-Durner, Valerie [0000-0002-6076-0111], Lelliott, Christopher J [0000-0001-8087-4530], Adams, David J [0000-0001-9490-0306], Mammano, Fabio [0000-0003-3751-1691], McKerlie, Colin [0000-0002-2232-0967], Herault, Yann [0000-0001-7049-6900], de Angelis, Martin Hrabě [0000-0002-7898-2353], Lloyd, KC Kent [0000-0002-5318-4144], Smedley, Damian [0000-0002-5836-9850], Apollo - University of Cambridge Repository, Queen Mary University of London (QMUL), European Bioinformatics Institute [Hinxton] (EMBL-EBI), EMBL Heidelberg, The Jackson Laboratory [Bar Harbor] (JAX), Baylor College of Medicine (BCM), Baylor University, University of Pennsylvania, The Hospital for sick children [Toronto] (SickKids), Mount Sinai Hospital [Toronto, Canada] (MSH), MRC Harwell Institute [UK], Helmholtz Zentrum München = German Research Center for Environmental Health, Institut Clinique de la Souris (ICS), Université de Strasbourg (UNISTRA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), French National Infrastructure for Mouse Phenogenomics (PHENOMIN), Institute of Molecular Genetics of the Czech Academy of Sciences (IMG / CAS), Czech Academy of Sciences [Prague] (CAS), The Wellcome Trust Sanger Institute [Cambridge], Technische Universität München = Technical University of Munich (TUM), Ludwig-Maximilians-Universität München (LMU), CNR - Italian National Research Council (CNR), Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), German Center for Diabetes Research - Deutsches Zentrum für Diabetesforschung [Neuherberg] (DZD), University of California [Davis] (UC Davis), University of California (UC), J C Ambrose, P Arumugam, E L Baple, M Bleda, F Boardman-Pretty, J M Boissiere, C R Boustred, H Brittain, M J Caulfield, G C Chan, C E H Craig, L C Daugherty, A de Burca, A Devereau, G Elgar, R E Foulger, T Fowler, P Furió-Tarí, J M Hackett, D Halai, A Hamblin, S Henderson, J E Holman, T J P Hubbard, K Ibáñez, R Jackson, L J Jones, D Kasperaviciute, M Kayikci, L Lahnstein, K Lawson, S E A Leigh, I U S Leong, F J Lopez, F Maleady-Crowe, J Mason, E M McDonagh, L Moutsianas, M Mueller, N Murugaesu, A C Need, C A Odhams, C Patch, D Perez-Gil, D Polychronopoulos, J Pullinger, T Rahim, A Rendon, P Riesgo-Ferreiro, T Rogers, M Ryten, K Savage, K Sawant, R H Scott, A Siddiq, A Sieghart, K R Smith, A Sosinsky, W Spooner, H E Stevens, A Stuckey, R Sultana, E R A Thomas, S R Thompson, C Tregidgo, A Tucci, E Walsh, S A Watters, M J Welland, E Williams, K Witkowska, S M Wood, M Zarowiecki, Susan Marschall, Christoph Lengger, Holger Maier, Claudia Seisenberger, Antje Bürger, Ralf Kühn, Joel Schick, Andreas Hörlein, Oskar Oritz, Florian Giesert, Joachim Beig, Janet Kenyon, Gemma Codner, Martin Fray, Sara J Johnson, James Cleak, Zsombor Szoke-Kovacs, David Lafont, Valerie E Vancollie, Robbie S B McLaren, Lena Hughes-Hallett, Christine Rowley, Emma Sanderson, Antonella Galli, Elizabeth Tuck, Angela Green, Catherine Tudor, Emma Siragher, Monika Dabrowska, Cecilia Icoresi Mazzeo, Mark Griffiths, David Gannon, Brendan Doe, Nicola Cockle, Andrea Kirton, Joanna Bottomley, Catherine Ingle, Edward Ryder, Diane Gleeson, Ramiro Ramirez-Solis, Marie-Christine Birling, Guillaume Pavlovic, Abdel Ayadi, Meziane Hamid, Ghina Bou About, Marie-France Champy, Hugues Jacobs, Olivia Wendling, Sophie Leblanc, Laurent Vasseur, Elissa J Chesler, Vivek Kumar, Jacqueline K White, Karen L Svenson, Jean-Paul Wiegand, Laura L Anderson, Troy Wilcox, James Clark, Jennifer Ryan, James Denegre, Tim Stearns, Vivek Philip, Catherine Witmeyer, Lindsay Bates, Zachary Seavey, Pamela Stanley, Amelia Willet, Willson Roper, Julie Creed, Michayla Moore, Alex Dorr, Pamelia Fraungruber, Rose Presby, Matthew Mckay, Dong Nguyen-Bresinsky, Leslie Goodwin, Rachel Urban, Coleen Kane, Herault, Yann, and Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université de Strasbourg (UNISTRA)
- Subjects
0301 basic medicine ,Mutation rate ,Cancer Research ,[SDV]Life Sciences [q-bio] ,General Physics and Astronomy ,methods [Genetic Association Studies] ,Disease ,VARIANTS ,Mice ,Essential ,0302 clinical medicine ,IMPC ,Genetics research ,Lethal allele ,2.1 Biological and endogenous factors ,Aetiology ,lcsh:Science ,Organism ,ComputingMilieux_MISCELLANEOUS ,Disease gene ,Mice, Knockout ,0303 health sciences ,Multidisciplinary ,Genes, Essential ,genetics [Disease] ,Genomics ,R/BIOCONDUCTOR PACKAGE ,DATABASE ,UPDATE ,GENOME ,[SDV] Life Sciences [q-bio] ,Knockout mouse ,Identification (biology) ,ddc:500 ,International Mouse Phenotyping Consortium ,Technology Platforms ,Biotechnology ,Knockout ,Science ,Computational biology ,Biology ,General Biochemistry, Genetics and Molecular Biology ,Article ,03 medical and health sciences ,Genetics ,medicine ,Animals ,Humans ,Genetic variation ,Clinical genetics ,Gene ,Genetic Association Studies ,030304 developmental biology ,Disease model ,Prevention ,Human Genome ,General Chemistry ,medicine.disease ,Developmental disorder ,Good Health and Well Being ,030104 developmental biology ,Genomics England Research Consortium ,Genes ,lcsh:Q ,Generic health relevance ,030217 neurology & neurosurgery ,Rare disease - Abstract
The identification of causal variants in sequencing studies remains a considerable challenge that can be partially addressed by new gene-specific knowledge. Here, we integrate measures of how essential a gene is to supporting life, as inferred from viability and phenotyping screens performed on knockout mice by the International Mouse Phenotyping Consortium and essentiality screens carried out on human cell lines. We propose a cross-species gene classification across the Full Spectrum of Intolerance to Loss-of-function (FUSIL) and demonstrate that genes in five mutually exclusive FUSIL categories have differing biological properties. Most notably, Mendelian disease genes, particularly those associated with developmental disorders, are highly overrepresented among genes non-essential for cell survival but required for organism development. After screening developmental disorder cases from three independent disease sequencing consortia, we identify potentially pathogenic variants in genes not previously associated with rare diseases. We therefore propose FUSIL as an efficient approach for disease gene discovery., Discovery of causal variants for monogenic disorders has been facilitated by whole exome and genome sequencing, but does not provide a diagnosis for all patients. Here, the authors propose a Full Spectrum of Intolerance to Loss-of-Function (FUSIL) categorization that integrates gene essentiality information to aid disease gene discovery.
- Published
- 2020
- Full Text
- View/download PDF
17. Prevalence of sexual dimorphism in mammalian phenotypic traits
- Author
-
Damian Smedley, Colin McKerlie, Xiang Gao, Henrik Westerberg, Simon Greenaway, Monica J. Justice, Hiroshi Masuya, Elissa J. Chesler, Robert E. Braun, Mary E. Dickinson, Shay Yaacoby, Stephen A. Murray, Karen L. Svenson, Jeremy Mason, Martin Hrabé de Angelis, Luis Santos, Tania Sorg, Christopher J. Lelliott, Sara Wells, Ann M. Flenniken, Ruth Heller, Ann-Marie Mallon, Lynette Bower, Karen P. Steel, Helen Parkinson, Judith E. Mank, Arthur L. Beaudet, Kevin C K Lloyd, Richard Mott, Yann Herault, Yoav Benjamini, Jacqueline K. White, Steve D.M. Brown, Shiying Guo, John R. Seavitt, Helmut Fuchs, Natalja Kurbatova, Anneliese O. Speak, Natasha A. Karp, Ramiro Ramirez-Solis, Terrence F. Meehan, David B. West, Shigeharu Wakana, The Wellcome Trust Sanger Institute [Cambridge], AstraZeneca [Cambridge, UK], European Bioinformatics Institute [Hinxton] (EMBL-EBI), EMBL Heidelberg, Baylor College of Medicine (BCM), Baylor University, Tel Aviv University (TAU), University of California [Davis] (UC Davis), University of California (UC), The Jackson Laboratory [Bar Harbor] (JAX), MRC Harwell Institute [UK], Helmholtz Zentrum München = German Research Center for Environmental Health, Technische Universität München = Technical University of Munich (TUM), German Center for Diabetes Research - Deutsches Zentrum für Diabetesforschung [Neuherberg] (DZD), Nanjing University (NJU), Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), Université de Strasbourg (UNISTRA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), French National Infrastructure for Mouse Phenogenomics (PHENOMIN), Institut Clinique de la Souris (ICS), The Hospital for sick children [Toronto] (SickKids), University College of London [London] (UCL), RIKEN BioResource Research Center [Tsukuba, Japan] (RIKEN BRC), Queen Mary University of London (QMUL), King‘s College London, Children's Hospital Oakland Research Institute (CHORI), International Mouse Phenotyping Consortium: Yuichi Obata, Tomohiro Suzuki, Masaru Tamura, Hideki Kaneda, Tamio Furuse, Kimio Kobayashi, Ikuo Miura, Ikuko Yamada, Nobuhiko Tanaka, Atsushi Yoshiki, Shinya Ayabe, David A Clary, Heather A Tolentino, Michael A Schuchbauer, Todd Tolentino, Joseph Anthony Aprile, Sheryl M Pedroia, Lois Kelsey, Igor Vukobradovic, Zorana Berberovic, Celeste Owen, Dawei Qu, Ruolin Guo, Susan Newbigging, Lily Morikawa, Napoleon Law, Xueyuan Shang, Patricia Feugas, Yanchun Wang, Mohammad Eskandarian, Yingchun Zhu, Lauryl M J Nutter, Patricia Penton, Valerie Laurin, Shannon Clarke, Qing Lan, Khondoker Sohel, David Miller, Greg Clark, Jane Hunter, Jorge Cabezas, Mohammed Bubshait, Tracy Carroll, Sandra Tondat, Suzanne MacMaster, Monica Pereira, Marina Gertsenstein, Ozge Danisment, Elsa Jacob, Amie Creighton, Gillian Sleep, James Clark, Lydia Teboul, Martin Fray, Adam Caulder, Jorik Loeffler, Gemma Codner, James Cleak, Sara Johnson, Zsombor Szoke-Kovacs, Adam Radage, Marina Maritati, Joffrey Mianne, Wendy Gardiner, Susan Allen, Heather Cater, Michelle Stewart, Piia Keskivali-Bond, Caroline Sinclair, Ellen Brown, Brendan Doe, Hannah Wardle-Jones, Evelyn Grau, Nicola Griggs, Mike Woods, Helen Kundi, Mark N D Griffiths, Christian Kipp, David G Melvin, Navis P S Raj, Simon A Holroyd, David J Gannon, Rafael Alcantara, Antonella Galli, Yvette E Hooks, Catherine L Tudor, Angela L Green, Fiona L Kussy, Elizabeth J Tuck, Emma J Siragher, Simon A Maguire, David T Lafont, Valerie E Vancollie, Selina A Pearson, Amy S Gates, Mark Sanderson, Carl Shannon, Lauren F E Anthony, Maksymilian T Sumowski, Robbie S B McLaren, Agnieszka Swiatkowska, Christopher M Isherwood, Emma L Cambridge, Heather M Wilson, Susana S Caetano, Cecilia Icoresi Mazzeo, Monika H Dabrowska, Charlotte Lillistone, Jeanne Estabel, Anna Karin B Maguire, Laura-Anne Roberson, Guillaume Pavlovic, Marie-Christine Birling, Wattenhofer-Donze Marie, Sylvie Jacquot, Abdel Ayadi, Dalila Ali-Hadji, Philippe Charles, Philippe André, Elise Le Marchand, Amal El Amri, Laurent Vasseur, Antonio Aguilar-Pimentel, Lore Becker, Irina Treise, Kristin Moreth, Tobias Stoeger, Oana V Amarie, Frauke Neff, Wolfgang Wurst, Raffi Bekeredjian, Markus Ollert, Thomas Klopstock, Julia Calzada-Wack, Susan Marschall, Robert Brommage, Ralph Steinkamp, Christoph Lengger, Manuela A Östereicher, Holger Maier, Claudia Stoeger, Stefanie Leuchtenberger, AliÖ Yildrim, Lillian Garrett, Sabine M Hölter, Annemarie Zimprich, Claudia Seisenberger, Antje Bürger, Jochen Graw, Oliver Eickelberg, Andreas Zimmer, Eckhard Wolf, Dirk H Busch, Martin Klingenspor, Carsten Schmidt-Weber, Valérie Gailus-Durner, Johannes Beckers, Birgit Rathkolb, Jan Rozman, univOAK, Archive ouverte, Mason, Jeremy [0000-0002-2796-5123], Chesler, Elissa J [0000-0002-5642-5062], Angelis, Martin Hrabe de [0000-0002-7898-2353], Herault, Yann [0000-0001-7049-6900], Lelliott, Christopher J [0000-0001-8087-4530], McKerlie, Colin [0000-0002-2232-0967], Wakana, Shigeharu [0000-0001-8532-0924], Yaacoby, Shay [0000-0002-2583-4170], and Apollo - University of Cambridge Repository
- Subjects
0301 basic medicine ,Genotype ,Science ,Mutant ,General Physics and Astronomy ,[SDV.GEN] Life Sciences [q-bio]/Genetics ,Quantitative trait locus ,Biology ,Article ,General Biochemistry, Genetics and Molecular Biology ,03 medical and health sciences ,Mice ,Quantitative Trait ,Quantitative Trait, Heritable ,Genetics ,Animals ,Modifier ,Gene ,Heritable ,Mammals ,Sex Characteristics ,[SDV.GEN]Life Sciences [q-bio]/Genetics ,Multidisciplinary ,Genes, Modifier ,Body Weight ,General Chemistry ,Phenotypic trait ,Phenotype ,Sexual dimorphism ,030104 developmental biology ,Genes ,Evolutionary biology ,Female ,International Mouse Phenotyping Consortium ,Sex characteristics - Abstract
The role of sex in biomedical studies has often been overlooked, despite evidence of sexually dimorphic effects in some biological studies. Here, we used high-throughput phenotype data from 14,250 wildtype and 40,192 mutant mice (representing 2,186 knockout lines), analysed for up to 234 traits, and found a large proportion of mammalian traits both in wildtype and mutants are influenced by sex. This result has implications for interpreting disease phenotypes in animal models and humans., Systemic dissection of sexually dimorphic phenotypes in mice is lacking. Here, Karp and the International Mouse Phenotype Consortium show that approximately 10% of qualitative traits and 56% of quantitative traits in mice as measured in laboratory setting are sexually dimorphic.
- Published
- 2017
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.